Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Biogelx: Cell Culture on Self-Assembling Peptide Gels.

Harper MM, Connolly ML, Goldie L, Irvine EJ, Shaw JE, Jayawarna V, Richardson SM, Dalby MJ, Lightbody D, Ulijn RV.

Methods Mol Biol. 2018;1777:283-303. doi: 10.1007/978-1-4939-7811-3_18.

PMID:
29744843
2.

Design of Treatment Trials for Functional Gastrointestinal Disorders.

Irvine EJ, Tack J, Crowell MD, Gwee KA, Ke M, Schmulson MJ, Whitehead WE, Spiegel B.

Gastroenterology. 2016 May;150(6):1469-1480.e1. doi: 10.1053/j.gastro.2016.02.010. Review.

PMID:
27147123
3.

Immunoassay arrays fabricated by dip-pen nanolithography with resonance Raman detection.

Laing S, Irvine EJ, Hernandez-Santana A, Smith WE, Faulds K, Graham D.

Anal Chem. 2013 Jun 18;85(12):5617-21. doi: 10.1021/ac4009012. Epub 2013 May 24.

PMID:
23697378
4.

Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004118. doi: 10.1002/14651858.CD004118.pub2. Review.

PMID:
23152224
5.

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease.

Blackhouse G, Assasi N, Xie F, Marshall J, Irvine EJ, Gaebel K, Campbell K, Hopkins R, O'Reilly D, Tarride JE, Goeree R.

J Crohns Colitis. 2012 Feb;6(1):77-85. doi: 10.1016/j.crohns.2011.07.007. Epub 2011 Sep 9.

PMID:
22261531
6.

Quality of life in patients with immune-mediated inflammatory diseases.

Russell AS, Gulliver WP, Irvine EJ, Albani S, Dutz JP.

J Rheumatol Suppl. 2011 Nov;88:7-19. doi: 10.3899/jrheum.110899. Review.

PMID:
22045973
7.

Fabricating protein immunoassay arrays on nitrocellulose using dip-pen lithography techniques.

Irvine EJ, Hernandez-Santana A, Faulds K, Graham D.

Analyst. 2011 Jul 21;136(14):2925-30. doi: 10.1039/c1an15178a. Epub 2011 Jun 7.

PMID:
21647488
8.

Development of the Crohn's disease digestive damage score, the Lémann score.

Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV Jr, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmerich J, Schreiber S, Tilg H, Travis S, van Assche G, Vecchi M, Mary JY, Colombel JF, Lémann M.

Inflamm Bowel Dis. 2011 Jun;17(6):1415-22. doi: 10.1002/ibd.21506. Epub 2010 Nov 28.

9.

Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China.

Zhou Y, Ren W, Irvine EJ, Yang D.

J Clin Nurs. 2010 Jan;19(1-2):79-88. doi: 10.1111/j.1365-2702.2009.03020.x.

PMID:
20500246
10.

Patient outcomes after anti TNF-alpha drugs for Crohn's disease.

Assasi N, Blackhouse G, Xie F, Marshall JK, Irvine EJ, Gaebel K, Robertson D, Campbell K, Hopkins R, Goeree R.

Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):163-75. doi: 10.1586/erp.10.13. Review.

PMID:
20384563
11.

Survey of access to gastroenterology in Canada: the SAGE wait times program.

Leddin D, Bridges RJ, Morgan DG, Fallone C, Render C, Plourde V, Gray J, Switzer C, McHattie J, Singh H, Walli E, Murray I, Nestel A, Sinclair P, Chen Y, Irvine EJ.

Can J Gastroenterol. 2010 Jan;24(1):20-5.

12.

Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.

Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J.

Can J Gastroenterol. 2010 Feb;24(2):113-20. Review.

13.

Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004115. doi: 10.1002/14651858.CD004115.pub2. Review.

PMID:
20091560
14.

Urinary potassium is a clinically useful test to detect a poor quality diet.

Mente A, Irvine EJ, Honey RJ, Logan AG.

J Nutr. 2009 Apr;139(4):743-9. doi: 10.3945/jn.108.098319. Epub 2009 Feb 11.

PMID:
19211830
15.

The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis.

Irvine EJ, Yeh CH, Ramsey D, Stirling AL, Higgins PD.

Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1278-86. doi: 10.1111/j.1365-2036.2008.03854.x. Epub 2008 Sep 19.

16.

Quality of life of patients with ulcerative colitis: past, present, and future.

Irvine EJ.

Inflamm Bowel Dis. 2008 Apr;14(4):554-65. Review.

PMID:
17973299
17.

A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls.

Ganguli SC, Kamath MV, Redmond K, Chen Y, Irvine EJ, Collins SM, Tougas G.

Neurogastroenterol Motil. 2007 Dec;19(12):961-7. Epub 2007 Sep 4.

PMID:
17931336
18.

Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Paré P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, Flook N, Collins SM.

Can J Gastroenterol. 2007 Apr;21 Suppl B:3B-22B. Review.

19.
20.

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR.

Gastroenterology. 2007 Feb;132(2):763-86. Epub 2006 Dec 20. Review. No abstract available.

PMID:
17258735

Supplemental Content

Loading ...
Support Center